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DEGENERATIVE ARTERIOPATHY WITH PULMONARY
HYPERTENSION: A REVISED CONCEPT OF SO-CALLED
PRIMARY PULMONARY HYPERTENSION
THOMAS N . JAMES, M.D.*

The etiology of so-called "primary" pulmonary hypertension is a current medical
enigma. It is not enigmatic for lack of attention, for there are a number of current
theories, capably reviewed by Dresdale'^ and McGuire-'. One of the popular theories
attributes the arterial histopathology to long-standing arterial spasm^"^ the cause of
which is unexplained. Another theory suggests repeated embolization, based on the
finding of apparent emboli in the small vessels of the lung at necropsy'"", but a
consistent demonstration of a source for such embolization has not been presented.
Although inexorably down hill, the clinical course of this disease is of considerable interest. One of the features which has attracted study is the frequency
of syncope, often as a presenting symptom^'^". Most explanations regarding this
syncope have been unsatisfactory, principally because they have failed to account
for the infrequency of syncope in patients with equal degrees of pulmonary
hypertension secondary to some demonstrable cause.
Following the recent demonstration of vascular lesions in the sinus node
and A V node of three patients with "primary pulmonary hypertension," it was
postulated that these lesions are the mechanism of both the frequently observed
syncope and sudden death". Perhaps more important than a possible explanation
of the mechanism of syncope and sudden death in these cases, however, is the fact
that the vascular lesions observed in the sinus node and AV node were in systemic
arteries. This makes the theory that the similar histopathology in the pulmonary
arteries is secondary to pulmonary hypertension less tenable.
An investigation of other systemic arteries in these three necropsied cases of socalled "primary" pulmonary hypertension has confirmed the observation that an
unusual process involves the walls of their systemic as well as pulmonary arteries.
For this reason the three cases being reported are diagnosed degenerative arteriopathy
with pulmonary hypertemion, which for the sake of brevity will be referred to as
DAPH. The cHnical and necropsy findings in all three fulfill the diagnostic criteria
of so-called "primary pulmonary hypertension".
CASE REPORTS
Case 1. M . B., a 31 year old white housewife, was admitted to the Henry
Ford Hospital on May 22, 1960, because of fainting spells. She was well until
syncopal bouts began 6 months prior to admission, progressively increasing in frequency so at the time of admission they were occurring several times daily. A l l
the episodes were preceded by palpitation. The first occurred during an emotional
upset, but subsequent ones had followed progressively decreasing amounts of physical
exertion. For two weeks prior to admission there was increasing cardiac failure
and dyspnea.
* Division of Cardiovascular Disease.
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She had had four normal pregnancies, with healthy children aged 12, 10, 8 and
6 years. In 1954 the patient had tubal ligation, and in October of 1957 a hysterectomy.
An uncle, aunt and the patient's mother had diabetes. Her father and four siblings
were alive and well.
On examination the patient was small, pale and of ectomorphic habitus. There
was no cyanosis nor clubbing; peripheral pulses were normal. The lungs were
resonant, with good breath sounds and no rales. Cardiac rhythm was regular at
90 per minute; blood pressure was 100/80 mm. Hg. A left parasternal heave
was present, with a systolic thrill in th3 left second intercostal space; the second
pulmonic sound was markedly accentuated and split, being followed by a soft
blowing diastolic murmur at the left sternal border. The liver edge was palpable at the
costal margin and tender, but did not pulsate. There was no peripheral edema.
An electrocardiogram showed right ventricular and right atrial hypertrophy with
sinus tachycardia. Other laboratory studies, including blood and urine sugar determinations, were normal. She was treated conservatively, discharged May 23, and
requested to return in one month for cardiac catheterization.
On June 26 a right cardiac catheterization was done by Dr. E. H . Drake.
Pressures in the pulmonary wedge position, main pulmonary artery and right ventricle were respectively (in mm. Hg) 10 mean, 110/45 and 115/5-20. A small
amount of oxygen desaturation in the femoral artery blood was raised to normal
when the patient breathed 100% oxygen. Oxygen content of blood from the
pulmonary arteries and right heart was normal. A diagnosis of primary pulmonary
hypertension was made and the patient was again discharged. Treatment included
digitoxin, hydrochlorothiazide and reserpine.
Syncope continued to increase in frequency, and her terminal admission was
August 19, at which time a new murmur of tricuspid regurgitation was present.
Cardiac rhythm was regular at 100 per minute. On August 20 an examiner noted
frequent premature beats, and that evening there was bigeminal rhythm; no electrocardiogram was made then but the one of August 19 showed normal sinus rhythm
and was unchanged from the one of May. During the night of August 21 the
patient was found dead in bed.
At necropsy both the right atrium and ventricle were dilated and hypertrophied.
There were no cardiac septal defects nor extracardiac shunts. The cardiac valves
were normal. A moderate degree of sclerosis was present in all arteries, including
the coronary arteries (Fig. 6). The sinus node artery and AV node artery both
arose from the right coronary artery at the usual sites-'-^'. There were no obvious
mural thrombi on gross inspection (see below). There were no gross pulmonary
emboli and no apparent peripheral sources for emboli.
Histology of the pulmonary arteries is shown
of "primary pulmonary hypertension". Notice the
the systemic arteries shown from the heart and the
same arteriopathy was less frequently seen in the
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in Figs. 1-5; it is characteristic
similarity to the arteriopathy of
adrenal gland (Figs. 7-15). The
kidney, spleen, and liver.

Pulmonary Hypertension
Involvement of the sinus node artery was characterized by a focal granular
degeneration of the tunica media, with some cyst formation and frequent hemorrhage (Fig. 7). An identical lesion was present in the AV node artery and some
of the pulmonary arteries of this case (Figs. 3 and 10), and has also been
described by others (Case 4 of Kuida, et al.^'). Note the resemblance of the
arteriopathy in the AV node and a larger ventricular artery (Figs. 6 and 12) to
the prevalent lesion in Case 2 (Figs. 17-22, 25-30).
A variety of stains were employed in an effort to identify the amorphous
material in the degenerated portion of the wall of the sinus node artery. It did
not stain as collagen with the Goldner trichrome stain. It was net metachromatic
with toluidine blue nor Alcian blue and was Schiff negative. It did not stain
with Oil Red O. It had no affinity for iron. On staining with acridine orange the
rim of the degenerating area fluoresced bright yellow under ultraviolet (Fig. 15),
but the majority of the material did not fluoresce; there was no fluorescence with
acriflavine, nor with any of the non-fluorochromatic stains. The material was not
basophihc for hematoxylin.
Similar histochemical analysis of the intimal proliferation in the pulmonary
arteries demonstrated that this process was SchilT positive, stained with Alcian
blue and with the Rinehart-Abul Haj colloidal iron stain, was not fluorescent with
any of the above stains, was not metachromatic with toluidine blue, and had no
basophilic character. This material was likely an acid mucopolysaccharide. The
endothelial proliferative process did not contain elastic fibers.
The old organized mural thrombus shown in Fig. 16 is directly underneath
the sinus node and occupies the antrum atrii dextri of the crista terminalis, a site
which S6derstr6m=" has indicated is a frequent one for atrial thrombosis. It is not
difflcult to see how such a thrombus may be overiooked, as it was in the gross
study of this case.

(B)

Figure 1
Small pulmonary artery from Case 1; note the
remarkable intimal endothelial proliferation and
the hypoplastic tunica media. Verhoeff-Van
Gieson stain with magnification in A X64 and
in B (sam.e artery) XI60.
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(A)

Figure 2
Another small pulmonary artery from Case 1,
with the smudgy degeneration of the tunica
media well shown under high power (A and
B). Goldner trichrom.e stain with magnification
in A X102 and in B (same artery) X256. C
shows a similar artery; acridine orange stain,
UV light, BG-12 filter, X64.

••••••

-

'..h

(A)

(B)

Figure 3
Small pulmonary artery from Case 1, demonstrating intramural degeneration and hemorrhage identical to that seen in the sinus node
artery (Fig. 7) and AV node artery (Fig. 10).
Goldner stain with magnification in A X40
and in B (same artery) X102.
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Two small pulmonary arteries of Case 1 with
emboli. Note the distention of the vessels and
the absence of attachment of the emboli to the
wall or of any cellular reaction in the wall. A
is stained with toluidine blue, XI60; B is stained
with Verhoeff-Van Gieson, X64.

I
Figure 5
A longitudinal section of a small pulmonary
artery from Case 1, demonstrating the intimal
proliferation and thin tunica media; VerhoeffVan Gieson, X64.

Figure 6
A left ventricular coronary artery from Case
1, exhibiting an "atheroma"; Goldner stain.
Magnification in A is X40 and B (same artery)
X160. Cystic degeneration of the tunica media
is apparent at the higher power.
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(A)

Figure 7
The sinus node artery from Case 1, with some
extravasation of blood into the node. The
granular compartmented degeneration with
hemorrhage is well seen at the higher power.
Goldner stain with magnification in A X64
and in B (same artery) X160.

Figure 8
A section through tne sinus node art'^ry of
Case 1 taken 16 mm. from the section in Fig.
7. The degeneration in the tunica media is
discernible at this magnification (X160) but is
less apparent at lower power. Goldner trichrome stain.

^A)

Figure 9
A section through the sinus node artery of
Case 1 taken 4 mm. from the one in Fig 7.
The internal and external laminae are intact,
but the degeneration of the tunica media is
obvious. Verhoeff-Van Gieson stain with magnification in A X64 and in B (same artery) X160.
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(A)

Figure 10
Artery to the AV node from Case 1, showing
focal intramural hemorrhage and degeneration
similar to that of the sinus node artery (Fig. 7)
and a pulmonary artery (Fig. 3). Goldner
stain with magnification in A X64 and in B
(same artery) XI60.

/

•* "' ' '
(UJ

(A)

Figure 11
Two views of another portion of the AV node
artery in Case 1, showing cystic degeneration
of the tunica media. Goldner trichrome stain
magnification in both A and B X160.

••

Figure 12
A third section through the AV node artery
of Case 1, showing still a difterent arteriopaphy
(although the same artery) from Figs. 10 and
11; the lesion here is primarily intimal proliferation and is identical to the predominant
lesion in Case 2. Note the process here begins
to comprise the lumen of the artery. Goldner
stain, X64.
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(A)

Figure 13
Three other abnormal myocardial arteries from
Case 1. .4 is from the right atrium, showing
an obliterative mixed intimal and medial proliferation; Goldner, X256. B is also from the
right atrium, with primarily medial degeneration; acridine orange stain with ultraviolet
light and BG-12 filter, X160. C is from the
right ventricle, showing cystic medial degeneration; Goldner, X160.

•aw- F

Figure 14
The wall of an adrenal artery from Case 1,
showing granular and cystic degeneration;
Goldner trichrome, X160.

(B)

Figure 15
A section of the sinus node artery from Case
1 taken near that in Fig. 7; note the fluorescent
rim in the area of maximal mural degeneration.
Acridine orange stain with ultraviolet light and
BG-12 filter; A X82, B (same artery) X160.
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Figure 16
Comparable sections of sinus nodes showing
the vacant antrum atrii dextri of the crista
terminalis in the normal (A) but the presence
of an old organized mural thrombus in Case
1 (B). Both Goldner stain, X4. The sinus
node can be seen about the artery in the upper
left corner of each photomicrograph, near the
epicardium; in B a focus of hemorrhage is
visible in the wall of the artery, but the extensive infarction of the node which was present
is not visible at this power.

Case 2. E. B., a 35 year old white unmarried schoolteacher, was delivered
at the Henry Ford Hospital October 31, 1924; her mother's pregnancy and the
dehvery were uncomplicated. Except for one examination for a minor feeding
problem in infancy, the patient was next seen July 6, 1950, complaining of weakness
of both legs present 4 months. She also described coldness and numbness of the
fingers on contact with cold for 3 years. Following hospitalization and extensive study,
the final diagnoses were post-influenzal asthenia and mild Raynaud's phenomenon.
In the review of symptoms she incidentally mentioned that she had been fainting
about 3 or 4 times a year, usually in church, for the past 4 years. She had no
other cardiac complaints and physical examination of the heart was normal. Erythrocytic sedimentation rate was 45 mm./hr., but other laboratory studies were
normal. No electrocardiogram was made.
In January of 1958 she again complained of weakness beginning after "flu,"
followed by exertional dyspnea, orthopnea and the development of visible pulsations
in the neck. After being ill for one month she was admitted to another hospital
for two weeks, where she was told her heart was enlarged and sent home to rest.
When her condition continued to deteriorate she returned to the Henry Ford Hospital
and was admitted April 2, 1958.
On this terminal admission peripheral cyanosis and orthopnea were noted.
The blood pressure was 105/60 mm. Hg but the sounds were faint. The femoral
pulse was regular at 120 per minute; the radial pulses were difficult to palpate.
The lungs were resonant and there were no rales. There was a left parasternal
heave and the second pulmonic sound was accentuated. No murmurs were audible.
Pulsations were present in the jugular veins; the liver was enlarged but not tender;
there was moderate pretibial edema.
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Except for a slight neutrophilia the blood studies were normal; repeated LE
cell preparations were negative. There were some granular casts and 2-\- albumin
in the urine. At fluoroscopy there was marked cardiac enlargement and cardiac
pulsations were virtually absent. An electrocardiogram on several occasions revealed
right ventricular hypertrophy and sinus rhythm.
The patient remained afebrile throughout her hospital course.

Two aspirations

from the pericardium yielded 80 cc. of clear fluid and 165 cc. of serosanguinous
fluid; these were negative for LE cells, and cultures were sterile. Despite conventional therapy for cardiac failure, this continued to increase, with the exception of
pulmonary edema, from which she remained free. Ascites appeared and increased.
On the 21st hospital day (April 23, 1958) she became more cyanotic, apprehensive,
and expired quietly.
At necropsy there was a small amount of serosanguinous

pericardial fluid.

The right ventricle and right atrium were dilated and hypertrophied.

Near the

apex of the right ventricle there was a mural thrombus with central liquefaction.
The arteries to the sinus node and A V node both arose from the right coronary
artery. The cardiac valves and septa were normal and there was no arteriovenous
shunt.

No peripheral thrombi were found and no atrial thrombi were recognized

on gross examination (see below).
The histologic appearance of the pulmonary arteries was characteristic of
"primary pulmonary hypertension" (Figs. 17, 18). Note their resemblance to the
arteriopathy present in the adrenals, brain, spleen, liver, kidneys and heart (Figs.
19-30).

Prevalence of the systemic arterial lesions was marked in the adrenals,

where virtually all the arteries were involved, and in the heart, especially the right
atrium and sinus and A V nodes; in other organs the lesions had to be sought. The
special similarity of the lesions in the adrenals, the heart and lungs is impressive.
Hemorrhage in the tunica media is seen in Fig. 24, similar to that of the sinus
node artery and some pulmonary arteries of Case 1. Histochemical studies in this
arteriopathy gave the same negative results as in Case 1. There was no significant
fluorescence with any of the stains studied.
As in Case 1 an antemortem thrombus was present underneath the sinus node
(Fig. 31), and was not recognized on gross inspection. In discussing such thrombi,
Soderstrom indicated that even though the portion of damaged atrial myocardium
bordering on these sinuses in the crista terminalis was very small, the ensuing thrombosis usually filled most of the sinuses^'. The possible role of emboli from such
thrombi relative to both pulmonary hypertension and pulmonary arteriopathy in
DAPH is the subject of later discussion.
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Figure 17
Two views of the same pulmonary arteriole
from Case 2, showing the typical intimal proliferation and the hypoplastic tunica media,
visibly degenerated at the higher magnification.
Goldner trichrome; A X64 and B X160.

Figure 18

Figure 19

Another small pulmonary artery from Case 2,
showing the same intimal prohferation and
medial degeneration as Fig. 17, plus the intact
intemal and external laminae. Verhoeff-Van
Gieson, X160.

An adrenal artery from Case 2, with obliterative
intimal proliferation. Hematoxylin and eosin,
X64.

Figure 20
Another adrenal artery from Case 2, showing
the same pathology as the pulmonary arteries
in Figs. 17 and 18. The basic similarity of the
arteriopathy in all the organs of each of the
three cases soon becomes apparent. VerhoeffVan Gieson; A X64, B (same artery) X160.
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Figure 21
Adrenal artery from Case 2; note the similarity
of this artery to those from the liver (Fig. 25)
and kidney (Fig. 26). Hematoxylin and eosin,
X64.

(A)

Figure 22
Two other adrenal arteries from Case 2, showing the basic pattern of intimal proliferation
and medial degeneration or hypoplasia. Verhoeft'-Van Gieson, X160 in both A and B.

4

„

.

(A)

Figure 23
Two small arteries from the brain of Case 2,
with granular focal degeneration in the tunica
media. Both A and B with Goldner stain at
X160.
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Figure 24

Figure 25

Small artery in the spleen of Case 2, with mural
hemorrhage. Goldner, X160.

Intimal prohferation and medial hypoplasia in
a small artery in the liver in Case 2. Goldner,
X160.

fc
Figure 26
The same basic arteriopathy as in the other
organs, shown here in the kidney of Case 2.
Goldner, X64.

(A)

(B)

Figure 27
Two views of a section of the left coronary
artery in Case 2, with an "atheroma." Goldner
stain; A XIO, B (same artery) X64.
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Figure 28
Two other coronary arteries from Case 2, A
showing remarkable intimal proliferation and B
smudgy medial degeneration. A is a branch of
the right coronary artery in the eustachian ridge
of the right atrium. Goldner. X64; B is "a
branch of the left coronary artery in the obtuse
margin of the left ventricle. Goldner, X160.

Figure 29
The artery to the AV node in Case 2, with the
lumen virtually occluded by intimal proliferation. Goldner, X82.

(A)

Figure 30
The sinus node artery from Case 2, showing
the same arteriopathy as the artery to the AV
node. All 3 views are of the same artery, Verhoeff-Van Gieson stain with A X40, B X64 and
C XI60. In B there is a gross defect in the
tunica media which has been replaced by the
intimal proliferative process; see text for a
discussion of this relationship, and its applicability to the pathogenesis of systemic atheroscierosis. In C the moth-eaten appearance of
the degenerating tunica media is well shown.
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Figure 31
.Antemortem mural thrombus in the antrum
atrii dextri of the crista terminalis of Case 2,
directly underlying the sinus node. Goldner,
XIO.

Case 3. I . M . , a 29 year old white married housewife and mother of two
children (ages 4 and 7) was referred to the Henry Ford Hospital from Grand
Rapids by Dr. Noyes L. Avery, Jr. She was admitted May 9, 1958, with complaints
of dyspnea and syncope which began 8 months previously. In October of 1957
she had been catheterized by Dr. Avery and the pressures in the wedged (pulmonary)
position, the pulmonary arteries and right ventricle were respectively (in mm. Hg)
4 mean, 120/50 and 120/12. Right atrial pressure was 16/8 and the pulse contour
suggested tricuspid valvular regurgitation. Oxygen contents were aU normal. The
diagnosis of primary pulmonary hypertension was made.
On admission to Henry Ford Hospital the patient was weak, orthopneic and
slightly cyanotic. Blood pressure was 124/90 mm. Hg and cardiac rhythm was
regular. There was a left parasternal heave and a blowing diastolic murmur along
the left sternal border, with a loud systolic murmur and thrill in the same area.
The second pulmonic sound was loud and split. There were no rales, but resonance
and breath sounds were diminished at the right lung base. The neck veins were
full and pulsating. Ascites was present.
NPN on admission was 70 mg. percent; there were granular casts and albumin
in the urine. Repeated LE cell tests were negative. Other blood studies were normal.
An electrocardiogram showed right ventricular hypertrophy and sinus rhythm.
Her course in the hospital was marked by increasing weakness, oliguria and
increasing right heart failure. She expired quietly on the fourth hospital day.
At necropsy there was dilatation and hypertrophy of the right atrium and right
ventricle; the valves and septa were normal; mural thrombi were adherent to the
endocardium of the right atrium near the sinus node, and the left ventricle. No
arteriovenous shunt and no peripheral thrombi were found. There was marked gross
atherosclerosis of the pulmonary arteries.

The sinus node artery arose from the

left circumflex coronary artery while the A V node artery arose from the right
coronary artery. Congestion was present in the lungs and all the abdominal viscera.
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Histology of the pulmonary arteries was characteristic of "primary pulmonary
hypertension" (Fig. 32). In addition to the typical intimal endothelial prohferation
and hypoplasia of the tunica media of the pulmonary arteries, there was an unusual
number of emboli present in the small arteries, though none were grossly identified.
Hemorrhage in the tunica media similar to that of Cases 1 and 2 is seen in Fig. 32 C.
Although the primary feature of the arteriopathy in the sinus node was a nonspecific proliferation of the tunica media (Fig. 33), focal degeneration and hemorrhage of the media, similar to that of Case 1, was also seen in other portions of
the sinus node artery (Fig. 34). Other examples of the systemic arteriopathy are
shown from the A V node, left and right ventricles, spleen

and adrenal

glands

(Figs. 35-40). Similar but much less frequent lesions were seen in the kidney and
liver. The medial hypertrophic process in the sinus node artery stained as collagen
rather than muscle on the Goldner trichrome stain.
The antemortem thrombus in the right atrium was recognized at gross inspection
in this case. As in the other two cases it was attached to the endocardium beneath
the sinus node and filled the anterior sinuses of the crista terminalis (Fig. 41).
It is the logical source for the emboli observed in the pulmonary arteries.

Figure 32
Pathology of the small pulmonary arteries of
Case 3. A (Goldner trichrome, X64) shows the
classical intimal proliferation with thin tunica
media. B (Verhoeff-Van Gieson, XI60) shows
a small pulmonary artery distended by an embolus; note the intimal hyperplasia in addition.
C (Goldner, X160) shows intramural hemorrhage in a small pulmonary artery.

*
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(A)

Figure 33
Three views of a section through the sinus node
artery of Case 3. The predominant pathology
here is a bizarre medial hyperplasia which
virtually obhterates the lumen of the artery;
there is some superimposed intimal proliferation visible inside the internal elastic lamina.
This type of process sometimes occurs in the
lungs, where it might be interpreted as "medial
hypertrophy". It is clear from the higher power
view in C that this is not a normal smooth
muscle hypertrophy. Verhoeff-Van Gieson; A
X40, B X82 and C X205.

•PS)

(C)

(A)

Figure 34
An oblique section through the sinus node
artery of Case 3, taken 12 mm. from the section
of the same artery shown in Fig. 33. Here there
is intramural degeneration and hemorrhage very
similar to that in the sinus node artery of Case
1. Goldner trichrome stain; A X64 and B
(same artery) X319.
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Figure 35

Figure 36

AV node artery of Case 3, showing intimal
proliferation in which the nuclei are plump; the
lumen of the artery is compromised. Goldner,
XI60.

The left coronary artery of Case 3, showing an
"atheroma" which is very similar to the coronary arteries of Cases 1 and 2. Goldner trichrome stain, XIO.

1

(A)

Figure 37
The main right coronary artery (A) and a right
ventricular branch (B) from Case 3; note the
"atheroma" with medial thinning in A. There
is cystic medial degeneration in the right ventricular branch. Goldner stain; A XIO and B
XI60.

Figure 38
Granular medial degeneration in a small artery
in the spleen of Case 3. Goldner, X319.
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Figure 39
Adrenal arteriopathy in Case 3. A shows a
bizarre intimal hyperplasia with a disorganized
tunica media; Verhoeff-Van Gieson, X64. B
shows granular degeneration and fragmenting
of the tunica media; Goldner, X160.

Figure 40
Another adrenal artery in Case 3, showing
pathology similar to Fig. 39B. Goldner trichrome stain; A X160 and B (same artery)
X319.

*4"'

(A)

Figure 41
Two views of the antemortem mural thrombus
of Case 3, attached to the endocardium directly
under the sinus node. A Goldner stain, XIO; B
Verhoefi'-Van Gieson, X25.
289
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CRITERIA FOR THE DIAGNOSIS OF DEGENERATIVE ARTERIOPATHY
W I T H PULMONARY HYPERTENSION
There is littie question that the cases of "primary pulmonary hypertension"
recorded in the literature represent a heterogenous group etiologically, a point emphasized by others^'^'"". A number of experienced observers have been impressed,
however, with the frequency of similarities in one particular group, characterized as
being represented by a young multiparous female with frequent bouts of syncope,
clinical and laboratory evidence of marked pulmonary hypertension, absence of an
arteriovenous shunt inside or outside the heart, absence of an apparent peripheral
source for pulmonary emboli, and uhimately a relentless downhill course due to
right ventricular failure^'"'. It seems likely that this is a "pure" group, although as
will be discussed later there are undoubtedly closely related and overiapping groups.
The conventional clinical and antemortem laboratory criteria for diagnosis of
"primary pulmonary hypertension" (or D A P H ) , briefly summarized below, have
been the subject of extensive description'"^' « " and do not therefore require fuller
development here. They are as follows:
1. The patient is characteristically a young multiparous female.
2. Syncope is a frequent presenting symptom and usually becomes an increasing
problem as the disease progresses; as a corollary, death is often sudden.
3. It is unusual to see cyanosis and peripheral edema eariy in the disease
but these may appear in later stages.
4. Syncope, chest pain, and dyspnea commonly follow exertion, and as the
disease progresses they occur with less and less stress.
5. Physical findings vary with the stage of the disease; early they are limited
to evidence of right ventricular enlargement and a pulmonary ejection type
murmur, with right ventricular failure minimal or absent. Later, right
ventricular failure progressively increases, and eventually regurgitant murmurs appear at both the pulmonic and tricuspid areas. Pulmonary congestion is rare.
6. Electrocardiograms demonstrate right ventricular and right atrial hypertrophy, which are also apparent radiographically; radiographs show no
pulmonary congestion and no left atrial enlargement, but the central pulmonary arteries are enlarged.
7. On cardiac catheterization the pulmonary wedge pressure is normal but
the pressure in the pulmonary arteries and right ventricle markedly elevated.
There is no evidence of arteriovenous shunting and, until late in the
disease, no peripheral oxygen desaturation. The increased hazard associated
with cardiac catheterization in these patients has been well documented^'''".
8. There is no evidence of a peripheral source for pulmonary emboli, no
intrinsic non-vascular pulmonary disease, and no evidence of systemic
290
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diseases known to be associated with arteriopathy, such as lupus erythematosus
or scleroderma.
Gross findings at necropsy consist of right ventricular and right atrial hypertrophy
and dilatation, and frequently grossly visible sclerosis of the larger pulmonary arteries.
Thickened smaller arteries may be visible on the cut surface of the lung. Small
emboli in the pulmonary arteries are commonly found, but larger emboli are not.
There are no cardiac septal defects nor any valvular lesions, though the pulmonic
and tricuspid valve rings may measure as slightly dilated. No peripheral thrombi
are present. Though intracardiac thrombi have only seldom been reported"'", small
intertrabecular thrombi in the right atrium and ventricle can easily be missed. Their
presence in all three of the present cases, as well as their potential role in the
pathogenesis of the pulmonary hypertension makes a careful gross and microscopic
search for them in future cases important.
Microscopic findings reported in the past have been limited almost exclusively
to those of the lungs. With few exceptions'""'" histology of other arteries has not been
reported, except in general terms as "negative". The frequency of emboli or thrombi
in the smaller pulmonary arteries varies considerably in reported cases. Most of
the pathological changes previously described in the smaller pulmonary arteries differ
little in DAPH from those found in secondary pulmonary hypertension, but the extent
of these changes is different. In DAPH remarkable intimal endothelial proliferation
(Figs. 1, 2, 17, 18, 32A) is more frequent and more striking. Some consider a
capillary proliferative ("glomoid") lesion highly suggestive". But the really significant
changes occur in the tunica media.
Bredt was among the first to be impressed by the medial degeneration seen
in the pulmonary arteries in "primary pulmonary hypertension'"'''. Later, Gilmour and
Evans'*' called attention to "aplasia or hypoplasia" of the media. Though Bredt as
well as Gilmour and Evans postulated that the medial degeneration was the primary
lesion and that pulmonary hypertension developed as a consequence, this postulate
remained speculative and the prevailing current interpretation has been that the
pulmonary arteriopathy is the consequence of the hypertension and not the cau.se
of it. The present demonstration of a similar arteriopathy in normotensive systemic
arteries of three patients with "primary pulmonary hypertension" now makes reevaluation of this question necessary.
Instead of extensive hypertrophy of the smooth muscle of the tunica media
of the pulmonary arteries, which is characteristic of most states associated with
pulmonary hypertension, the arteries of the lungs of patients with DAPH show a
singular lack of such response. When one searches carefully enough, a few vessels
with medial hypertrophy may be found in DAPH, but these are exceptional and
by far the prevalent lesion is the medial degeneration and hypoplasia. Conversely,
on careful search of the lungs from cases of secondary pulmonary hypertension
medial degeneration or hypoplasia is occasionally encountered, but again this is the
exceptional lesion.
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The medial degenerative changes are characteristic. Though these sometimes
show small cyst formation, somewhat similar to Erdheims' cystic medial necrosis"'"',
they are more typically a ground-glass or finely granular degeneration of the smooth
muscle fibers (Figs. 28, 7B, 8, 9B, 30C). Significantly, there is no associated
inflammatory cellular response. In other arteries a pyknotic degeneration of the
nuclei of arterial smooth muscle occurs, perhaps as an earlier stage. Intimal hyperplasia or proliferation is usually associated with underiying medial atrophy or hypoplasia. In most areas both the internal and external elastic membranes remain intact,
but occasionally the former becomes slightly frayed. All these lesions are segmental
or focal, and serial sectioning demonstrates that the same artery may appear normal
in one area but diseased further o n ' ' » .
Since the specific arteriopathy in the three present patients differs in some
arteries from others, one may consider whether the three patients all represent the
same disease. For example some arteries show recent medial degeneration with
hemorrhage while others show intimal proliferation and hyperplasia. Since all these
lesions were present in one artery or another in all three patients, it is probable
that they all are the same disease and that these variations in arteriopathy are more
apparent than real.
In general the arteries with recent medial degeneration

showed little intimal

response, while those with extensive intimal response showed no recent disease in
the tunica media, which was, however, usually atrophic or hypoplastic. It is reasonable to believe, therefore, that the medial changes are the initial ones and that the
intimal response is secondary to this, the difference in histologic appearance thus
depending on the time of examination in the natural course of the arteriopathy.
Presuming the basic pathology is a generalized degenerative

arteriopathy, one is

still faced with the need for explaining the higher prevalence of the lesion in the
lungs. This is the subject of later discussion.
One type of arterial medial response in DAPH may be confused with conventional
medial hypertrophy seen in secondary

pulmonary hypertension.

The sinus node

artery of Case 3 illustrates this process: note whereas the tunica media is tremendously
"hypertrophied", this hypertrophic process does not include normal smooth muscle
but is formed of relatively non-specific cells (Fig. 33). Comrast this to the hypertrophy of smooth muscle seen in the pulmonary arteries in secondary pulmonary
hypertension (Fig. 42). Thus though a sort of medial proliferative process may be
seen in arteries in DAPH, it is not a normal smooth muscle response to increased
work. Possibly it is a non-specific fibroblastic reparative response"' to smooth muscle
degeneration in the tunica media. That it is not an unusual smooth muscle hypertrophy
(e.g. longitudinal fibers) responding to the increased work demands of pulmonary
hypertension is suggested by the presence of an identical process involving systemic
arteries.
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(A)

Figure 42
Smooth muscle hypertrophy in small pulmonary
arteries of two patients with secondary pulmonary hypertension. A and B are from a
19 year old male with severe pulmonary hypertension and reversed flow in a patent ductus
arteriosus; C is from a 29 year old female with
severe puliron.iry hypertension due to an interatrial septal defect. Contrast the relatively
orderly smooth muscle hypertrophy here with
the bizarre medial proliferation in Fig. 33. A
Verhoeff-Van Gieson, X32. B Goldner. X82.
C Goldner X82.

Of considerable importance in differentiating the arterial lesion of DAPH from
other arteriopathies is the absence of any inflammatory cellular response to the
degeneration. There are no giant cells nor a leukocytic response, which helps to
distinguish it from most of the arteriopathies associated with the "collagen" diseases.
In Case 3 there were a large number of mast cells around the arterial lesions of the
lung, but not about the systemic arterial lesions; in the other two cases there were
no more mast cells than normally seen in relation to blood vessels.
SIGNIFICANCE OF SYSTEMIC ARTERY INVOLVEMENT
Involvement of the arteries to the sinus node and A V node, which are systemic
arteries, explains the syncope and sudden death which are commonly observed in
"primary pulmonary hypertension". Others have occasionally noted involvement of
various systemic arteries of patients dying with this disease, but have either interpreted
it vaguely or could not be certain they were not coincidental lesions. This particular
arteriopathy in the cardiac nodes must be accepted as an integral part of the basic
disease process, since the clinical features it produces are accepted as an integral
part of the basic clinical picture of "primary pulmonary hypertension".
In their discussion of the etiologic factors involved in "so-called primary pulmonary hypertension", Rawson and Woske"^ described one case in whom extrapulmonary arterial lesions were found; these consisted primarily of a perivascular
cellular reaction and no details are given of the histology of the walls of these
arteries. On the basis of this and the clinical symptoms of 3 other cases, plus a review
of the symptoms of reported cases in the literature, they suggested that "primary
pulmonary hypertension'' may be related to the "collagen" group of diseases.
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Although the arguments of Rawson and Woske are consonant with the concept
of "primary pulmonary hypertension" as a systemic disease, the systemic arterial
histopathology in their case was somewhat different from that observed in the three
present cases. The similarity of the medial involvement in these three cases in both
the systemic and pulmonary arteries, as well as its similarity to the process in
pulmonary arteries described by Gilmour and Evans"=, Bredt"", Wade and Ball"", Kuida
et aP', and Berthrong and Cochran"', suggests that this is a specific arteriopathy.
There are probably cases of atypical collagen diseases with somewhat similar changes;
these may represent intermediary or overiapping forms inevitably found in virtually
all arteriopathies."'"^'
There is littie question that severe hypertension is often associated with necrosis
of the tunica media, and the frequency of this phenomenon in malignant systemic
arterial hypertension makes the previous presumption that such changes in the pulmonary arteries were also the consequence of abnormally elevated pressure plausible.
Some of the changes observed in the media still quite likely are the consequence
of hypertension, but the presence of similar changes in non-hypertensive systemic
arteries makes it unlikely that hypertension is the only cause. It is possible that
some of the arteriopathy in the lung involves bronchial (systemic) arteries rather
than hypertensive pulmonary arteries.
PATHOGENESIS OF THE PULMONARY HYPERTENSION
Some substance present in the venous blood returning to the right heart and
lungs has long been postulated as a possible cause of pulmonary arterial and
arteriolar spasm eventually leading to irreversible vascular damage and right heart
failure. The basic flaw in this theory has been the inability to identify such a substance in patients with the disease. The present findings do not refute this possibility,
but they do indicate several previously unrecognized factors at least contributing to
the hypertension.
One of these factors is the demonstration of a source for embolism to the
lung.

A l l three of the present patients had mural thrombi in the right atrium

(Figs. 16, 31, 41); in two of the three cases the thrombus was not detected at the
time of gross examination, but was demonstrated microscopically. Since various stages
of injury were present in the sinus node of all three cases, varying from old fibrosis
to recent hemorrhage, it seems reasonable to believe that this area is the site of
repeated small infarctions and associated mural thrombosis. Repeated embolization
of small fragments from these thrombi would be unlikely to produce clinically
recognizable bouts of pulmonary embolism, but in association with a pulmonary
arterial bed already diseased it could readily lead to a vicious cycle of events (Fig. 43).
Repeated attacks of transient arrhythmias during the syncopal attacks could further
contribute to right atrial stasis and thrombus formation.
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A scheiTiatic indication of the factors involved in production of pulmonary hypertension in DAPH.

Emboli from the endocardium beneath the sinus node may produce pulmonary
hypertension in three ways. Mechanical obstruction is the first of these, but it is
improbable it is a major factor because of the relatively small size of the initial
mural thrombus as well as the lack of recognition of clinical episodes suggesting
pulmonary embolism in these patients. More likely the small emboli have a more
chronic effect by stimulating an arterial proliferative process demonstrable experimentally'"''". The third effect involves the possible release of serotonin from the
mural thrombus as well as the small emboli from it; this substance has been demonstrated to be a powerful stimulator of pulmonary vasoconstriction''''
The latter effect
is likely operative only while active thrombosis is present and capable of releasing
serotonin from disintegrating platelets, but how often in the course of DAPH active
mural thrombosis is occurring is unknown.
The seeming inadequacy or inertia of the pulmonary arterial media, as expressed
by its failure to hypertrophy under the hypertensive stimulus, suggests another interesting hypothesis. If the tunica media which is later seen to degenerate is at an earlier
stage simply weak, arteriolar dilatation may be expected to occur. According to
LaPlace's law, the pressure in a hollow chamber (in this case the artery) is directly
proportional to the tension in the chamber wall and inversely proportional to the
radius of the chamber. Thus if the tension in the arterial wall decreased, in order
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to maintain the same pressure the radius of the artery would have to decrease.
Since the weakened media is incapable of doing this via spasm, the usual physiologic
means, one may reason teleologically that the body takes another recourse by intimal
endothelial proliferation.* That the intimal proliferation corresponds to points of
medial hypoplasia, as observed by Gilmour and Evans and also in the three present
cases, may mean that the body has attempted to heal a point of medial weakness.
The beautiful concentric intimal proliferation so characteristic of DAPH may thus
be the consequence of evenly distributed concentric medial weakness, and the focal
"atheroma" the consequence of focal medial weakness. The possible relationship of
the same hypothesis to pathogenesis of systemic atherosclerosis will be discussed later.
Demonstration that priscoline and acetylcholine are capable of transiently lowering
the pressure in the pulmonary arteries of patients with "primary pulmonary hypertension"''"'" suggests vasospasm is present, but it has not defined the cause of the
vasospasm. Because of consideration regarding a neurogenic cause' thoracic sympathectomy has been attempted as treatment, but the patient did not improve". More
recentiy attention has been direeted to the possible effect of serotonin, and its ability
to produce a type of arteriopathy"'"; this seems an unlikely major factor because
of the absence of other findings due to increased circulating .serotonin seen in
malignant carcinoid. Perhaps more suspicion should be directed at epinephrine and
norepinephrin, particulariy in view of the presence of adrenal arteriopathy in all
3 of the current cases. Though relatively weak pulmonary vasocontrictors, these
catecholamines potentially have other effects on the pulmonary arterial wall which
may lead to luminal obstruction; this will be developed more fully subsequently.
Whether vasospasm is due to some substance circulating in the blood or due
to a neurogenic reilex, perhaps related to repeated small embolisms, there is no
doubt that organic obstructive lesions are present in the majority of authentic cases
of "primary pulmonary hypertension". One cause for these lesions is embolism, but
for a more complete understanding of the disease it is necessary to define the nature
of the primary degenerative changes in the arterial wall.
ETIOLOGIC POSSIBILITIES REGARDING
THE DEGENERATIVE ARTERIOPATHY
Although the present findings do not exclude the role of a noxious venous
substance in the pathogenesis of DAPH, it is not necessary to explain the disease
on this basis. The pulmonary hypertension and clinical course can all be explained
on the basis of the degenerative arteriopathy without the presence of such a substance.
The medial weakness as a possible cause of intimal proliferation has already been
discussed, and the manner in which this would contribute to hypertension if unchecked
is apparent; the additional occurrence of repeated small emboli from recurring mural
thrombosis near the sinus node would aggravate and accelerate this process, ultimately
causing it to become self-propagating: the pulmonary hypertension producing more
"'A lucid differentiation of intimal elastic hyperplasia, commonly .seen in atheroma, and intimal
endothelial proliferation, which is uncommon except in "primary pulmonary hypertension" is
made by Brenner^'. Both processes are seen in DAPH.
.' . ' f
• •
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arterial medial damage which through intimal proliferation would in turn lead to
more hypertension (Fig. 43).
What then are the possible causes of the degeneration in the tunica media'.'
There is a resemblance to the medial lesions of Marfan's syndrome and many other
heritable disorders of connective tissue"''". In both diseases sudden death is a common
phenomenon, and the possibility that it is sometimes due to involvement of the nodal
arteries in Marfan's syndrome as well as in DAPH is now being investigated. Cystic
medial degeneration occurs in the pulmonary artery in both diseases and ruptured
dissecting aneurysm of the main pulmonary artery has been described in "primary
pulmonary hypertension"""". The histology of the media of the aorta in the three
present cases was normal, but this needs to be studied further in other cases of
DAPH. Similarly the histology of the smaller pulmonary arteries needs to be examined
in Marfan's syndrome, as well as in experimental lathyrism""". Recently vascular
lesions were produced in swine fed a copper-deficient diet", an observation which
deserves further study.
If a specific degenerative process of the tunica media of certain arteries is the
primary pathology in DAPH, this may be either congenital or acquired. Much the
same analysis regarding these possibilities may be applied to DAPH as to Marfan's
syndrome"'". Since a familial incidence of "primary pulmonary hypertension" has
been observed' ' " , it will be important to determine if any relatives of patients with
heritable disorders of connective tissue develop DAPH. Berthrong and Cochran
suggested unexplained pulmonary hypertension in children may be associated with
an increased incidence of congenital cardiovascular malformations (themselves not
producing the pulmonary hypertension)"'. If it is an acquired lesion, there has so
far been no explanation of how it becomes acquired. It is possible there is a
hereditary predisposition which, in combination with some process which would
otherwise be innocuous, results in arterial medial degeneration in these susceptible
patients.
One possible means of acquisition of the arteriopathy which has impressed
numerous observers is pregnancy. The primary problem with accepting pregnancy
as the only process responsible for DAPH is the observation of the disease in women
who have never been pregnant (Case 2, e.g.), as well as some acceptable cases
in males"'"'". The placenta or the gravid uterus as the possible source of a substance
aggravating or even producing DAPH can only be accepted if there are also other
causes. A number of other cardiovascular diseases seem equally obscurely related to
menstruation and pregnancy"""'.
That pregnancy and breeding have an influence on arteries is well documented.
It has been demonstrated that experimental animals repeatedly bred are more susceptible to atherosclerosis than non-bred controls". The occurrence of dissecting
aortic aneurysm in pregnancy has been reported numerous times, and its possible
relationship to hormonal derangements of pregnancy have been the subject of
study'""'"". Aortic dissection in experimental lathyrism is reported to be more frequent
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in male than female animals'^, but the histology of the pulmonary arteries in these
animals has not been reported.
Among endocrine secretions possibly responsible, one which has some experimental and clinical observations to support it is the thyroid stimulating hormone
(TSH). It has recently been reported that the administration of high levels of
TSH produces certain degenerative myxomatous changes in muscle"' somewhat suggestive of the lesion in the tunica media of DAPH. These changes did not occur
in control animals treated with thyroid hormone alone. Some years ago Kountz
and Hempelmann reported the occurrence of dissecting aortic aneurysm in three
consecutive patients with severe systemic hypertension treated with thyroidectomy"',
and convincingly argued that the thyroidectomy and dissection were related; these
patients presumably developed elevated levels of TSH. Myxomatous degenerative
changes in the heart and in the coronary arteries have long been recognized as
commonly occurring in myxedema"'""' and have been presumed to be related partly
to elevated cholesterol levels; perhaps the TSH level in these patients is equally
important.
Also deserving consideration in the etiology of the degenerative arteriopathy
are epinephrin and norepinephrin, which are capable of producing arterial lesions
experimentally'""". A very similar change is sometimes seen in the pulmonary
arterioles of patients with pheochromocytoma (Fig. 44, 45). In all three of the
present patients there was arteriopathy present in the adrenal glands, involving
occasional arteries in Cases I and 3, but virtually all the adrenal arteries in Case 2
(Figs. 14, 19-22, 39, 40). Furthermore the process in the adrenal arteries was the
same as the process in other systemic arteries and the pulmonary arteries in each
case, as well as characteristic of lesions generally described in "primary pulmonary
hypertension" in the lungs by others.

(A)

Figure 44
Two small pulmonary arteries from the lungs
of a young woman who died of pheochromocytoma. Note the similarity of the arteriopathy
to many of the arteries in Cases 1, 2 and 3.
A (Goldner, X64) shows intimal proliferation
with a thin tunica media. B (Goldner, X64)
shows focal intimal proliferation over an area
of medial thinning.
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(B)

(A)

Figure 45
Pulmonary arteriopathy in another case of fatal
pheochromocytoma, this in a middle-aged male.
A and B are the same artery, Goldner stain, at
X64 and XI60; there is a small amount of intimal prohferation, with edematous endothelial
cells overlying it, and with a disorganized and
degenerate tunica media underlying it. Another
artery with a similar process is shown in C
(Goldner, X160), with the cystic changes in
the tunica media clearly seen.

How often there is extensive adrenal arteriopathy in DAPH cannot be stated
from observations in 3 cases. Since it was extensive in one of the three, however,
the possible role of adrenal ischemia must be considered. During right heart failure
which is common in DAPH, right atrial and peripheral venous pressure rises, and
this must include pressures in the inferior vena cava and adrenal veins. Such venous
hypertension coupled with the fall in aortic pressure which occurs would be further
aggravated by luminal lesions in the adrenal arteries, thus suggesting that a disproportionate ischemia must occur in the adrenal glands, similar to that affecting the
cardiac nodes, where the arteries are similarly involved. That adrenal ischemia is
associated with increased elaboration of pressor agents has been suggested from experiments.It is reasonable to presume, therefore, that an excessive amount of epinephrin or norepinephrin (or both) will reach the pulmonary arteries in patients with
DAPH at least intermittently.
Since epinephrin and norepinephrin have been shown to be only weak pulmonary
vasoconstrictors in animals and normal man'""", the presence of pulmonary arteriopathy in patients with pheochromocytoma is puzzling. The lesion illustrated in
Fig. 45 suggests edema or slight proliferation of the intimal endothelium; there
were in addition arteries with a moderate degree of smooth muscle hypertrophy
and some cystic degeneration; occasional arteries resembling those of DAPH were
also found (Fig. 44). Others have described extensive smooth muscle hypertrophy,
as well as degenerative changes of various types in the tunica media of the pulmonary
arteries of patients with pheochromocytoma" '". The pressure in the pulmonary arteries
of such patients has not been measured, so it is improper to presume that it is not
elevated because of experimental observations in animals or in man without pheochro-
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mocytoma. It is not known what the response of the arteries in "primary pulmonary
hypertension" is to epinephrin and norepinephrin, though their hypotensive response
to adrenolytic agents has been repeatedly observed''''^
Regarding the sexual predilection of DAPH, it has been shown that women s
conjunctival arterioles become exquisitely sensitive to epinephrin during menstruation".
Conceivably the preponderance of DAPH in women in the child-bearing age is related
to this observation. It may be well to study the response of the conjunctival arterioles
to various pressor agents in patients with DAPH.
Despite these intriguing implications, it is unlikely epinephrin or norepinephrin
is the major factor in DAPH. Absence of systemic hypertension indicates there
is no increase in total circulating catecholamines. Presence of systemic arterial lesions
indicate the arteriopathy probably occurs without abnormal blood pressure elevation.
The evidence suggests that epinephrine or norepinephrin may contribute intermittently
to the pulmonary hypertension and arteriopathy, however, and this possibility deserves further investigation.
Recently attention has been directed to serotonin as a possible etiologic factor
in "primary pulmonary hypertension", its powerful vasospastic effect on the pulmonary
circulation being well known. Administration of serotonin has produced a pulmonary
arteriopathy in rabbits but failed to do so in rats." Since nature has provided a
specific human example of the effect of excessive secretion of serotonin in the
malignant carcinoid syndrome, and since its clinical and pathologic characteristics""''""
are considerably different from those of DAPH, it seems unlikely that serotonin is a
significant factor in the latter. Resemblance of pulmonary arteriopathy in one case
of malignant carcinoid syndrome to DAPH (Fig. 46), however, suggests further
study of this question.

Figure 46
Two small arteries from the lung of a patient
with malignant carcinoid syndrome (other
features of this case previously reported from
this institution""). Note the intimal proliferation and the thin tunica media. A stained
with Verhoeff-Van Gieson, X64; B stained
with Goldner trichrome, X160.

On the basis of present evidence it is difficult to determine the cause of the
generalized degenerative arteriopathy. An inherited or acquired (or both) defect
of the tunica media seems likely, but its cause is unclear. Both the hypertension
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and some of the arteriopathy in the lungs is related to recurring small emboli from
right atrial thrombi due to sinus node infarction, and in turn some of the arteriopathy
is likely due to hypertension. Most of the possible humoural substances which could
cause pulmonary hypertension and arteriopathy seem less important in view of
systemic arterial involvement with normal systemic arterial pressure; this does not
exclude such substances as contributory factors.
What we see in the histopathology of the pulmonary arteries may only be the
consequence of chance involvement of certain systemic arteries (those of the cardiac
nodes, right atrium and adrenal glands, e.g.) and have relatively littie to do with
the basic process of a generalized degenerative arteriopathy. In other words it is
possible we are being misled by the striking pulmonary arteriopathy which leads
to one type of death from a generalized arterial disease, the other possible consequences of which we do not know. In particular we do not know what the
natural history of the disease would be in cases where the arteries of the adrenal
glands, right atrium and cardiac nodes may be spared.
Even without an adequtae explanation for the degenerative arteriopathy, its
similarity to systemic atherosclerosis merits some discussion. This is particularly
true since all three of these young women had considerable coronary arteriopathy
indistinguishable morphologically from atherosclerosis, which is most unusual at their
ages in their sex.
CONSIDERATIONS RELATIVE TO ATHEROSCLEROSIS
A N D ARTERIOSCLEROSIS
In their description of medial hypoplasia in "primary pulmonary hypertension"
Gilmour and Evans"' called attention to the applicability of their observations to
systemic atherosclerosis. A better understanding of healing and repair in any arteriopathy may well shed light on the pathogenesis of arterial sclerosis.
From a study of atherosclerotic systemic arteries fixed while being distended
by intraluminal fluid under pressure, Crawford and Levene""""'" demonstrated that
an atheroma in most cases did not protrude into the arterial lumen, the way we
are accustomed to seeing it in fixed undistended arteries, but that the lumen retained
quite a well-rounded shape and that the atheroma instead bulged into the media.
The remaining tunica media beneath the atheroma was considerably thinned out.
It was shown that this medial thinning could not be simple pressure atrophy due
to the atheroma being pressed into previously normal tunica media, for it is mathematically impossible for the pressure on the media beneath a covering to be
higher than that on normal media near by; in fact pressure on media beneath the
atheroma is less.
If the tunica media is the site of focal degeneration, two consequences affect
normal vascular hemodynamics (Fig. 47). First the focus of weakened tunica media
may retain sufficient strength to prevent aneurysmal bulging, but would after atrophy
present a cavity toward the lumen of the vessel. It may be expected that this
cavity will become filled in order to restore a smooth contour to the inner surface
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of the vessel. Whatever the exact filling process, whether by thrombus or by intimal
proliferation, or both, the end result will be a "scar" histologically indistinguishable
from an atheroma.
Figure 47
A schematic representation of the consequences
of injury to a small focus (left vertical column)
and to the entire wall (right vertical column)
of an artery. Stippling at step A indicates the
area of injury. In B the results of a loss of
mural substance are stresses in the directions
indicated by the arrows; with focal injury there
are two stresses, one a direct centrifugal thrust
favoring aneurysmal bulging (y), and the other
a dividing force (x) since the intact smooth
muscle encirclement of the artery has been disrupted. At the second step in the right column
where there has been a symmetrical loss of substance of the entire arterial wah, the consequent
weakening causes symmetrical centrifugal thrust
and dilatation. In step C the healing of these
two types of arterial damage is indicated; with
focal damage the repair is a conventional
atheroma, which fills the defect in the tunica
media thus dampening the aneurysmal centrifugal thrust at that point as well as rejoining
the intact remainder of the smooth muscle
circle; with more generalized mural damage
(right column) a symmetrical endothehal proliferation is the only means of reducing the
arterial radius and restoring pressure (see text
for discussion), since the damaged tunica
media is unable to do this by spasm or contraction. Step D shows the arteries as they are
viewed in an undistended postmortem state,
the atheroma on the left bulging into the lumen.'
Both types of damage are seen in DAPH; the
type in the right column is uncommon in any
other disease.

The second consequence of a focus of weakened tunica media is an impairment
of the efficiency of the unweakened remaining fibers of smooth muscle. For normal
function the smooth muscle of the tunica media depends on the maintenance of an
mtact circle about the vessel'- '"'. When a segment of this circle is damaged, normal
intravascular pressure will force apart the remainder of the circle and thereby increase
the diameter of this segment of vessel. A healing of this defect in the tunica media
would not only fill in the cavity on the inner surface of the vessel, thus discouraging
the aneurysmal centrifugal thrust, but would also link together again the surviving
smooth muscle fibers and restore their efficiency in maintenance of "active tension"""
of the vessel wall. Most discrete atheromata admirably serve both these purposes.
Afler long-standing or repeated bouts of damage to the tunica media this simple
manner of healing must be replaced by a disorderiy process in which focal hemorrhage, neighboring degeneration, calcification, and superimposed thrombosis all contribute. By the time most systemic atherosclerosis becomes clinically manifest and
by the time opportunity for histological study at necropsy occurs, the simple atheroma
with Its exquisitely efficient natural reparative process is no longer to be seen.
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If the atheroma is initially an efficient reparative process, why do we then
sometimes see arteries which are virtually occluded by simple atheroma? These
may of course partly be artefacts seen in collapsed, undistended arteries. They may
also be instances of a different process which is only morphologically similar, but
they are probably the same process. One explanation may be the body has no
efficient checking or suppressing mechanism once atheroma formation has begun.
In different patients this may apply to all atheroma formation, or may differ from
artery to artery at any one time or at different times. For example, patients with
high levels of circulating fat moities may so fill any developing atheroma with these
substances that it gorges and distends it to the point of occluding the arterial lumen.
Another explanation of why the body will construct an atheroma which eventually encroaches on the arterial lumen can be made, however. According to LaPlace's
law, which has been shown applicable to normal vascular dynamics by Burton'"',
pressure is directly proportional to tension and inversely proportional to radius. In
application to blood vessels, P = T is interpreted thus: P is the intravascular
r
pressure, T is the tension produced by the vessel wall, and r is the mean radius
from the center of a cross-section of the vessel to an average mid-point between
endothelium and outer adventitia.
Accepting the applicability of LaPlace's law to the dynamics of blood vessels,
it is axiomatic that any decrease in pressure due to failure of tension can only be
compensated by a reduction of the vessel's radius. With a small focus of medial
damage an atheroma may re-link the undamaged smooth muscle so it may restore
normal mural tension, but with a large focus of medial damage this may not be
possible and pressure can then be restored only by an intimal proliferative reduction
in radius. The consideration of similar variations in these factors (P, T and r) as
they relate to vascular pathophysiology is beyond the scope of the present discussion,
but it is impressive that in all these the applicability of LaPlace's law remains valid.
In DAPH one of the hallmarks of the histopathology is the beautiful concentric
reduction of the arterial lumina by radially oriented intimal proliferation (Figs. 1,
2, 17, 18, 32A). Less well recognized previously is the almost universal accompanying
medial atrophy which sometimes involves the entire ring of tunica media in that plane.
If the entire circumference of the tunica media at this point is weakened, a logical
means of restoring local pressure, since the tunica media is unable to do this with
constriction, is for the arterial radius to be reduced by concentric intimal proliferation.
Analogy of DAPH and systemic atherosclerosis, including similarities in their
pathogenesis, is supported by the amount of coronary atherosclerosis present in the
hearts of the three young women in this report. Significant coronary atherosclerosis
is singularly uncommon in young women'"'""" except in the presence of diabetes,
systemic hypertension or other vascular diseases, one of which may be DAPH.
Though extensive coronary atherosclerosis has not been considered characteristic of
"primary pulmonary hypertension," systemic arteries in this disease have previously
seldom been studied with the care given to the pulmonary arteries.
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There is no dearth of possible considerations on the etiology of the damage to
the tunica media in any arteriopathy. Cystic medial degeneration can occur as a consequence of impairment of mural blood supply"" and Schlichter'" has produced such
lesions by coagulating the adventitia of the aorta. The essence of what is being suggested,
however, lies in considering the atheroma formation as secondary to such damage rather
than responsible for it. This is not to say that intimal proliferation or hyperplasia, once
begun, does not aggravate the medial damage, for it probably does. Whatever the
initial cause for medial degeneration, thickening of the overlying intima (even for
the salutary purpose of strengthening and repair) removes or certainly impairs one
possible route of nourishment to at least the inner third of the tunica media.'""^ Thus
the artery while attempting to heal itself is partially defeating its own purpose.
SIMILARITIES OF DAPH TO COLLAGEN DISEASES,
A N D SOME IMPORTANT DIFFERENCES
Resemblance of some features of DAPH to collagen diseases is apparent, and it
has been suggested that "primary pulmonary hypertension" is a variant form of this
group of diseases"". Among these, notable similarities exist between DAPH and lupus
erythematosus, Raynaud's disease, or scleroderma. In all these diseases a comparison
of the typical case of DAPH to a typical case of lupus or scleroderma or Raynaud's
disease allows one to distinguish with ease the striking clinical differences, which are
too familiar to require repetition. It is more difficult to separate the atypical cases.
Histologically one of the significant differences is the lack of inflammatory
cellular reaction to the degeneration in DAPH, whereas the vasculitis of the collagen
diseases is usually associated with a periarterial cellular response."" Prevalence of the
arterial lesions in various organs is of additional differentiating aid, the vascular
pathology of the kidney and spleen in lupus being much more extensive than in DAPH;
also in lupus the glomerular capillaries are a prominent site of involvement, whereas
in DAPH these seem to be spared. This latter difference between the two diseases
applies to other organs as well, lupus tending to spare medium size and larger arteries,
whereas DAPH characteristically involves them. Finally, even though the lung and
right atrium may be involved in collagen disease, this is an unusual occurrence, whereas
these are the site of extensive pathology in DAPH.
Raynaud's phenomenon, a feature of Case 2, is now considered as etiologically
non-specific.'" It is commonly a feature of the clinical course in the collagen diseases,
but is also commonly seen in association with many other diseases. Raynaud's disease
has been reported to involve the pulmonary vessels,'""" but this is unusual. Since it
has not previously been appreciated that systemic degenerative arteriopathy occurs
in "primary pulmonary hypertension," it remains to be determined whether some of
the reported cases of pulmonary involvement by Raynaud's disease or by certain
collagen diseases may not actually be DAPH.
Undoubtedly this whole group of diseases is closely related, and a too rigid
separation of them may be both difficult and undesirable. Shadings of difference exist,
and abundant opportunity for misdiagnosis in either direction must occur.
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MECHANISM OF SYNCOPE A N D SUDDEN D E A T H
Although this topic is the subject of a fuller development elsewhere,"" a brief
disucssion is appropriate to this report. In the 3 cases reported here the lesions involving the cardiac nodal arteries were of two types. The first was a hemorrhagic
and cystic or granular degeneration of the tunica media of the sinus node artery with
ultimate rupture into the sinus node (Fig. 7 ) . The second type of lesion was a combination of both intimal and musculoelastic hyperplasia which produced luminal encroachment (Figs. 29, 30, 33, 35). That the second is a likely consequence of the first has
already been discussed.
Concomitant with the development of these focal lesions in the nodal arteries
in DAPH, the progressive disease in the pulmonary arteries has two effects relative
to syncope and sudden death. The first of these is a compromise of the blood flow
through the lungs which impairs filling of the left side of the heart and thereby
cardiac output into the aorta and coronary arteries. The second, also a consequence
of rising pulmonary vascular resistance, is a development of right ventricular hypertension and at least intermittently elevation of right atrial pressure with resistance
to coronary sinus flow. The combination of decreased central aortic pressure and
elevated right atrial pressure results in a marked reduction in effective coronary perfusion pressure.'"'"" This reduction in coronary artery flow ma.y be expected to
produce generalized myocardial hypoxia, but when it occurs in conjunction with
lesions specifically compromising flow in the nodal arteries, an intense focal ischemia
of the sinus node and A V node may be anticipated. In DAPH this focal ischemia
is most likely the major determinant of the syncope and sudden death.
In addition to focal nodal ischemia, other factors contribute to the pathogenesis
of syncope and sudden death. For example, distention of the right atrium is a
powerful stimulus for a vagomimetic reflex which may depress function of the
sinus node or A V node or both'" '"; this influence would be expected to occur in
secondary pulmonary hypertension of any etiology, suggesting that this factor alone is
insufficient to produce syncope or sudden death except in occasional cases. Similarly
ischemia of the nodes as part of a generalized myocardial ischemia, without the
selective vascular involvement seen in DAPH, is apparently not sufficient of itself
to produce clinical evidence of nodal dysfunction else it should be observed more
frequently in any pulmonary hypertension. Analogous observations may be made
regarding cerebral anoxia, pulmonary vascular reflexes, retrograde flow of right atrial
hypoxemic venous blood into the sinus node and A V node, and other factors which
can occur in any pulmonary hypertension. For further details regarding these
mechanisms and a consideration of their applicability to the marked increase in hazard
of cardiac catheterization in these patients, the reader is referred to the separate
communication dealing specifically with them"".
THERAPEUTIC CONSIDERATIONS
At present there is no satisfactory treatment for DAPH. On consideration of
the various etiologic theories, appropriate therapeutic measures have been suggested
and attempted with only modest and inconsistent success. The direct instillation of
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acetylcholine or priscoline into the pulmonary artery has been shown to reduce
pressure there'"'", but this has been evanescent, the pressure immediately returning
to pre-treatment levels when the drug was discontinued. Although this establishes
that there is a component of spasm contributing to the pressure elevation in the
disease, it is quite likely that the disease would progress even if the element of
spasm were removed. One must even give some consideration to the possibility
that without spasm (and the consequent high levels of pressure) perfusion of blood
through some of the narrowed non-spastic arteries might fail altogether, with subsequent thrombosis and occlusion compounding the pulmonary perfusion problem.
In addition, any of the pulmonary vasodilators reaching the systemic circulation may
further reduce central aortic pressure and thereby worsen the already lowered effective
coronary perfusion pressure.
On the contrary it is perhaps worth considering the employment of systemic
vasopressor substances to raise central aortic pressure, especially during a syncopal
crisis or similar acute deterioration in patients with DAPH. This would produce
an elevation in effective coronary perfusion pressure and could be expected to improve
the coronary circulation lo the nodes and myocardium. Norepinephrin, which is a
profound systemic pressor agent and weak pulmonary pressor agent would be preferrable to metaraminol in DAPH, for the latter affects both circulations equally.
Against this possible benefit, however, must be weighed the potential risk of rupturing
weakened arteries, as in the sinus node or lungs.
Because of the theory that "primary pulmonary hypertension" was due to multiple
miliary embolization, use of anticoagulants has been suggested"". In consideration of
the role of repeated small embolizations from a mural thrombus near the sinus
node in DAPH, anticoagulants may be expected to be beneficial. This effect would
only eliminate the thromboembolic component of the progressive disease in the
pulmonary arteries, however, and would not necessarily alter the medial degeneration
and compensatory intimal proliferation. If hemorrhagic cystic lesions of the sinus
node artery and pulmonary arteries similar to those observed in Case 1 prove to be
frequent in DAPH, the hazard they present in dissection and rupture under the
influence of anticoagulants must be considered.
Because of the constant likelihood of sudden dysfunction of the sinus node and
AV node in DAPH, the effect of digitalis and quinidine in this regard should be
considered when they are chosen for therapy. This is not to imply they should
be avoided in DAPH if conventional indications are present, but one should be
aware of the potential results of depression of sinus node activity or A V node
conduction.
Since the arteriopathy is devoid of inflammatory cellular response, there is no
reason to anticipate benefit from adrenal cortical steroids. The possibility of an
important role being played by adrenal medullary hormones deserves further investigation, however, and if they are important in the pulmonary hypertension and
arteriopathy, certain measures are available to control this factor.
SUMMARY A N D CONCLUSIONS
Based on observations in 3 cases, evidence is presented that the disease known
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as "primary pulmonary hypertension" is a degenerative arteriopathy in which pulmonary
hypertension is a devastating but secondary phenomenon. Because of the consistent
finding of a pathologic process involving normotensive systemic arteries in these
three patients, it is suggested that hypertension can not be the only cause of the
degenerative arteriopathy.
Whether all cases presently classified as "primary pulmonary hypertension" prove
lo be DAPH or not, it seems apparent that DAPH is a distinct disease. In those
cases of "primary pulmonary hypertension" in whom syncope or sudden death are
features of the clinical course, a careful examination of the arteries to the two nodes
of the heart is now important. It must be emphasized that this involvement of the
arteries to the nodes is segmental, however, and anything less than a thorough study
with sections made at most 2 millimeters apart may miss the diseased segments.
All three patients had adrenal arteriopathy, and in one of these it was extensive.
Based on this and certain other considerations it is suggested that the role of the
adrenal medullary hormones be further evaluated regarding the pathogenesis and
evolution of certain features of DAPH.
In view of the demonstration of systemic arterial involvement in this disease
which was previously generally considered lo be almost exclusively pulmonary, a
number of implications regarding other arteriopathies suggest themselves and have
been discussed. Prominent among these is the pathogenesis of systemic atherosclerosis.
The expected benefits and hazards of certain forms of therapy are considered
in light of these new observations.
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